Taking more medication than prescribed constitutes poisoning under ICD-10-CM drug-event rules. The drug may have been correctly prescribed, but the patient took an incorrect amount.

For poisoning, the applicable poisoning code is generally sequenced first, followed by codes identifying manifestations such as gastrointestinal bleeding.

This differs from an adverse effect, in which a drug is correctly prescribed and properly administered but causes an undesirable reaction. In adverse-effect scenarios, the nature of the adverse effect is coded first, followed by the drug code with the appropriate adverse-effect character.

Underdosing applies when the patient takes less of a medication than prescribed, whether intentionally or unintentionally. It does not describe excessive dosing.

For CDI specialists, determining whether an event represents poisoning, adverse effect, or underdosing requires careful review of how the medication was prescribed and actually taken. Phrases such as “warfarin-related bleeding” may not always provide enough information to determine the correct classification.

A clarification query may therefore be appropriate when dose, intent, or medication-use circumstances are unclear.

CCDS Reference Topics: Poisoning; adverse effects; underdosing; medication events; sequencing.

=========

The laboratory trajectory strongly supports consideration of acute kidney injury (AKI). The creatinine increased from 0.9 to 1.5 mg/dL, an absolute increase of 0.6 mg/dL over 48 hours and approximately 1.67 times the baseline value. Combined with decreased urine output, this represents a clinically significant acute change in renal function.

The key distinction is the acute change from baseline. A single creatinine value cannot reliably establish AKI because renal function must be interpreted in context, including baseline creatinine, fluid status, urine output, medications, hemodynamics, and other contributing factors.

Chronic kidney disease requires evidence of persistent kidney abnormality over time rather than an isolated rapid deterioration. End-stage renal disease represents advanced irreversible kidney failure and is not supported by this scenario. Nephrotic syndrome is characterized by a different constellation including heavy proteinuria, hypoalbuminemia, and edema.

The CDI specialist should not independently diagnose AKI. Instead, the laboratory trend and reduced urine output create an appropriate basis for a provider query when no corresponding diagnosis has been documented.

CCDS Reference Topics: Renal pathophysiology; AKI clinical indicators; baseline comparison; diagnostic clarification.

=========

ICD-10-CM provides category I22 for a subsequent acute myocardial infarction occurring within four weeks—28 days—of an initial acute MI, when the qualifying MI types and circumstances meet the classification requirements.

The FY 2026 Official Guidelines specify that when a patient with a type 1 or unspecified acute MI experiences a new type 1 or unspecified MI within four weeks of the initial MI, a code from category I22 is used together with the appropriate I21 code. Sequencing depends on the circumstances of the encounter.

This rule requires care because type 2 MI and certain other myocardial infarction classifications do not follow the same I22 subsequent-MI logic. CDI specialists therefore need accurate documentation of MI type, anatomic location when applicable, timing, and whether the current event represents a genuinely new infarction rather than ongoing care for the original MI.

The prior STEMI does not become an “old MI” merely because the patient left the hospital; the ICD-10-CM acute MI period extends for four weeks from onset.

CCDS Reference Topics: Acute MI; subsequent MI; I21/I22; four-week rule; cardiovascular coding.

=========

The findings strongly support severe symptomatic hyponatremia. A serum sodium of 116 mEq/L represents marked reduction in extracellular sodium concentration, and the neurologic manifestations—confusion and seizures—indicate clinically significant cerebral effects.

Severe hyponatremia can produce cerebral edema because reduced extracellular osmolality promotes water movement into brain cells. Symptoms can range from nausea and headache to confusion, seizures, coma, and respiratory arrest in extreme cases.

Administration of hypertonic saline further demonstrates that clinicians are treating a significant sodium disturbance rather than an incidental laboratory abnormality. The rate of sodium correction requires careful monitoring because overly rapid correction, particularly in chronic hyponatremia, can cause osmotic demyelination.

Heart failure can contribute through impaired free-water excretion and neurohormonal activation, but CDI should not independently assign the etiology unless the provider documents it.

The specialist should present the sodium level, symptoms, treatment, and clinical course and request clarification if no corresponding diagnosis exists.

Hypernatremia represents elevated rather than decreased sodium. Hypercalcemia and respiratory alkalosis do not explain the sodium abnormality.

CCDS Reference Topics: Hyponatremia; electrolyte physiology; neurologic manifestations; clinical indicators; documentation specificity.

=========

Case mix index is calculated as:

Total MS-DRG relative weights ÷ Total inpatient discharges

Therefore:

4,375 ÷ 2,500 = 1.75

The hospital's CMI is 1.75.

CMI provides an aggregate indication of the average relative resource intensity of the hospital's inpatient population. Because each MS-DRG carries a relative weight, hospitals treating larger numbers of complex medical or surgical cases typically have higher CMIs than hospitals treating less resource-intensive populations.

CMI is not a direct quality score and should not be interpreted as a pure measure of CDI performance. It can change because of service-line mix, surgical volume, patient acuity, transfers, annual MS-DRG recalibration, coding accuracy, documentation quality, and other operational changes.

CMS maintains the FY 2026 MS-DRG Definitions Manual and grouper logic, currently Version 43.1 for April 1 through September 30, 2026.

A CDI manager should therefore analyze unexpected CMI changes alongside service-line trends, query activity, coding reconciliation, procedure volumes, and diagnosis patterns.

CCDS Reference Topics: CMI; relative weights; CDI analytics; MS-DRGs; trend analysis.

=========

ICD-10-CM presumes a causal relationship between hypertension and chronic kidney disease when both are documented, unless the provider specifically states that the conditions are unrelated. Therefore, the working coding logic should recognize hypertensive CKD and additionally identify the patient's CKD stage.

The FY 2026 Official Guidelines direct assignment of a code from category I12, Hypertensive chronic kidney disease, when hypertension and a condition classified to N18.- are both present. An additional N18.- code is required to identify the CKD stage. In this case, the documented stage is 3b.

A provider query solely to establish the hypertension-CKD relationship is unnecessary because ICD-10-CM itself supplies the presumed relationship. However, a query could become necessary if the physician explicitly states or strongly suggests that the CKD is unrelated to hypertension or if conflicting documentation exists.

The CDI specialist must distinguish coding conventions that automatically establish certain relationships from situations in which provider linkage is mandatory. This prevents unnecessary queries and supports accurate working-DRG assignment.

CCDS Reference Topics: Hypertensive CKD; presumed causal relationships; CKD staging; coding conventions; working MS-DRG.

=========

An MS-DRG relative weight represents relative expected resource consumption, not a direct severity score or mortality probability. Therefore, a relative weight of approximately 2.0 means the MS-DRG is associated with roughly twice the resource intensity of the average case represented by the standardized reference point.

CMS calculates and recalibrates MS-DRG relative weights using national hospital data as part of IPPS rate setting. The FY 2026 final-rule materials include the MS-DRG weighting factors as well as supporting cost data used in the relative-weight methodology.

Clinically complex cases often consume more resources, so relative weight may correlate with severity. However, it is not equivalent to a patient's severity-of-illness score or risk-of-mortality score. Likewise, hospitals do not simply multiply their billed charges based on the DRG weight. IPPS payment involves the standardized amount plus various adjustments, including wage index and other applicable payment factors.

For CDI, accurate documentation matters because diagnoses and procedures drive MS-DRG assignment, and the assigned MS-DRG carries its specific relative weight.

CCDS Reference Topics: IPPS; MS-DRG relative weight; resource consumption; reimbursement methodology.

=========

The principal concern is the selective destruction of unanswered queries. A compliant query-retention policy should be consistent, defensible, and auditable rather than dependent on whether the physician provided a response or whether the query affected billing.

Organizations may structure query retention differently depending on legal requirements, health-record policy, technology, and organizational governance. Queries may be part of the permanent health record or retained as another retrievable business record, depending on policy. The key point is that disposition should not be manipulated to hide unanswered or inconvenient clarification activity.

Destroying unresolved queries can impair auditability, create an appearance that the organization is selectively preserving only favorable documentation activity, and undermine the integrity of the CDI process.

The 2026 ACDIS/AHIMA guidelines are the current foundational standard for query-practice design and supersede prior versions.

A query need not automatically remain in the permanent medical record forever; retention requirements depend on applicable organizational and legal policies. What is unacceptable is an inconsistent approach designed to remove evidence based on outcome.

CCDS Reference Topics: Query retention; compliance; auditability; organizational policy; documentation integrity.

=========

A condition documented in the medical record does not automatically qualify as a reportable secondary diagnosis. For inpatient coding, additional diagnoses generally must be clinically significant during the current hospitalization. Qualifying significance includes clinical evaluation, therapeutic treatment, diagnostic procedures, an extended length of stay, or increased nursing care and/or monitoring.

Here, GERD is merely part of the patient's historical medical background and does not affect current management. Therefore, it generally should not be reported as an additional diagnosis solely because it appears in the past medical history.

Whether a diagnosis is classified as a CC or MCC is a separate issue. A condition must first satisfy applicable reporting requirements before its MS-DRG severity classification matters. CDI specialists should never encourage coding of clinically irrelevant historical conditions merely because they could affect reimbursement.

This principle protects the clinical integrity of coded data and prevents inappropriate inflation of disease burden. CDI review should focus on conditions that meaningfully describe the patient's current hospitalization, treatment requirements, clinical risk, and resource consumption.

CCDS Reference Topics: Reporting additional diagnoses; secondary-diagnosis criteria; medical-record review; resource utilization; coding compliance.

=========

When the admission is for management of anemia associated directly with the malignancy, and treatment is directed only at the anemia, the malignancy is sequenced as principal diagnosis, followed by the appropriate anemia code.

The FY 2026 Official Guidelines specifically distinguish malignancy-associated anemia from anemia caused by chemotherapy. For anemia associated with the malignancy, the neoplasm is sequenced first. For anemia resulting from an adverse effect of chemotherapy or immunotherapy, the anemia code is sequenced first.

This distinction makes documentation of anemia etiology essential. Phrases such as “anemia in cancer patient” may not clearly establish whether anemia is attributable to malignancy, chemotherapy, bleeding, nutritional deficiency, chronic kidney disease, or another process.

An encounter code for transfusion does not replace the principal-diagnosis rules for an inpatient hospitalization when the underlying reason for treatment is established.

Likewise, weakness is a symptom and would not supersede the definitive documented cancer-related anemia.

CDI professionals should therefore look beyond the fact that transfusion occurred and identify whether the medical record clearly establishes the cause of the anemia.

CCDS Reference Topics: Neoplasm-related anemia; principal diagnosis; sequencing; chemotherapy versus malignancy; medical record specificity.

=========